GI
VRTX icon

GLG Inc’s Vertex Pharmaceuticals VRTX Stock Holding History

GLG Inc’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$1.59M Hold
21,342
– – 0.04% 413
2013
Q3 		$1.62M Buy
21,342
+10,899
+104% +$867K 0.03% 467
2013
Q2 		$834K Buy
+10,443
New +$769K 0.02% 489

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GLG Inc's VRTX Position: Q4 2013 in Review

GLG Inc held its Vertex Pharmaceuticals (VRTX) position steady in Q4 2013 at 21,342 shares worth $1.59M. The position accounts for 0.04% of the portfolio, ranked #413.

GLG Inc first reported a position in VRTX in Q2 2013 and has held it in 3 quarters since. The position peaked at $1.62M in Q3 2013. 386 funds tracked by Wall St. Rank hold VRTX as of Q4 2013.

  • GLG Inc held 21,342 shares of Vertex Pharmaceuticals worth $1.59M as of Q4 2013.
  • GLG Inc left its Vertex Pharmaceuticals share count unchanged in Q4 2013.
  • Vertex Pharmaceuticals made up 0.04% of GLG Inc's portfolio in Q4 2013, its #413 holding.
  • GLG Inc first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 3 quarters since.
  • GLG Inc's Vertex Pharmaceuticals position peaked at $1.62M in Q3 2013.
  • 386 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2013.

Based on GLG Inc's 13F filing for Q4 2013, filed 14 Feb 2014.